News
Personalised Immunotherapy Therapies Inching Closer- Study
In an effort to advance personalised cancer treatment, researchers have shown that biomarkers alone cannot predict which patients will benefit most from immunotherapy.
Clinicians should...
Drug Research
EMA Develops A Quality Control Group To Aid Drug Development
To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices...
Press Releases
Amarin Goes for Growth with New UK and Ireland General Manager
Amarin Pharmaceuticals Ireland Limited plans to drive forward the next phase of its commercial expansion with the major new appointment of Scott Curley to...
IT & Data Management
An Identification Result Doesn’t End at the Report
You are evaluating your identification results for an unknown isolate – what does this organism mean to your manufacturing process, your final product, and...
Drug Research
RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore
RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency...
News
CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore Pharma Market by 2030
Continuing the winning streak of CPhI & P-MEC India, Informa Markets, the leading international B2B events group is once again back with its 15th...
Drug Research
Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity
Merck, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read